Europe — EMA
Palonosetron Kalceks
Palonosetron, the active ingredient in Palonosetron Kalceks, is a 5-HT3 receptor antagonist presented as a injection solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Kalceks, is a 5-HT3 receptor antagonist presented as a injection solution for intravenous use. It treats and helps prevent chemotherapy‑induced nausea and vomiting in cancer patients.
GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Palonosetron used for?
Palonosetron is a selective 5‑HT3 antagonist that blocks the serotonin pathway involved in nausea and vomiting. - Chemotherapy‑induced nausea and vomiting (CINV): Prevents both acute and delayed CINV in adult adult patients. - Post‑operative Post‑operative nausea : -
